Annual Cash & Cash Equivalents
$92.93 M
-$9.37 M-9.16%
31 December 2023
Summary:
TG Therapeutics annual cash & cash equivalents is currently $92.93 million, with the most recent change of -$9.37 million (-9.16%) on 31 December 2023. During the last 3 years, it has fallen by -$460.51 million (-83.21%). TGTX annual cash & cash equivalents is now -83.21% below its all-time high of $553.44 million, reached on 31 December 2020.TGTX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$195.82 M
+$112.91 M+136.19%
30 September 2024
Summary:
TG Therapeutics quarterly cash and cash equivalents is currently $195.82 million, with the most recent change of +$112.91 million (+136.19%) on 30 September 2024. Over the past year, it has increased by +$44.92 million (+29.77%). TGTX quarterly cash and cash equivalents is now -64.62% below its all-time high of $553.44 million, reached on 31 December 2020.TGTX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TGTX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.2% | +29.8% |
| 3 y3 years | -83.2% | -40.0% |
| 5 y5 years | +121.5% | +338.3% |
TGTX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -83.2% | at low | -40.0% | +218.6% |
| 5 y | 5 years | -83.2% | +121.5% | -64.6% | +338.3% |
| alltime | all time | -83.2% | >+9999.0% | -64.6% | >+9999.0% |
TG Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $195.82 M(+136.2%) |
| June 2024 | - | $82.91 M(+9.8%) |
| Mar 2024 | - | $75.48 M(-18.8%) |
| Dec 2023 | $92.93 M(-9.2%) | $92.93 M(-38.4%) |
| Sept 2023 | - | $150.90 M(+55.6%) |
| June 2023 | - | $97.01 M(+57.8%) |
| Mar 2023 | - | $61.47 M(-39.9%) |
| Dec 2022 | $102.30 M(-65.8%) | $102.30 M(-6.9%) |
| Sept 2022 | - | $109.86 M(-25.3%) |
| June 2022 | - | $147.07 M(-20.8%) |
| Mar 2022 | - | $185.68 M(-37.9%) |
| Dec 2021 | $298.89 M(-46.0%) | $298.89 M(-8.5%) |
| Sept 2021 | - | $326.51 M(-18.7%) |
| June 2021 | - | $401.71 M(-14.8%) |
| Mar 2021 | - | $471.51 M(-14.8%) |
| Dec 2020 | $553.44 M(+391.3%) | $553.44 M(+117.8%) |
| Sept 2020 | - | $254.15 M(-2.4%) |
| June 2020 | - | $260.51 M(+400.5%) |
| Mar 2020 | - | $52.05 M(-53.8%) |
| Dec 2019 | $112.64 M(+168.5%) | $112.64 M(+152.1%) |
| Sept 2019 | - | $44.67 M(-21.9%) |
| June 2019 | - | $57.23 M(-11.1%) |
| Mar 2019 | - | $64.35 M(+53.4%) |
| Dec 2018 | $41.96 M(-26.0%) | $41.96 M(-40.7%) |
| Sept 2018 | - | $70.72 M(-33.1%) |
| June 2018 | - | $105.67 M(+27.5%) |
| Mar 2018 | - | $82.90 M(+46.2%) |
| Dec 2017 | $56.72 M(+126.6%) | $56.72 M(-38.2%) |
| Sept 2017 | - | $91.84 M(+18.3%) |
| June 2017 | - | $77.60 M(-18.9%) |
| Mar 2017 | - | $95.64 M(+282.1%) |
| Dec 2016 | $25.03 M(-54.5%) | $25.03 M(-14.1%) |
| Sept 2016 | - | $29.16 M(+2.0%) |
| June 2016 | - | $28.58 M(-21.7%) |
| Mar 2016 | - | $36.48 M(-33.7%) |
| Dec 2015 | $55.06 M(-1.2%) | $55.06 M(-15.9%) |
| Sept 2015 | - | $65.46 M(+8.6%) |
| June 2015 | - | $60.30 M(-29.9%) |
| Mar 2015 | - | $86.00 M(+54.4%) |
| Dec 2014 | $55.71 M(+37.6%) | $55.71 M(+4.7%) |
| Sept 2014 | - | $53.23 M(+43.6%) |
| June 2014 | - | $37.08 M(-25.2%) |
| Mar 2014 | - | $49.60 M(+22.5%) |
| Dec 2013 | $40.49 M(+146.0%) | $40.49 M(-19.3%) |
| Sept 2013 | - | $50.18 M(+274.0%) |
| June 2013 | - | $13.42 M(-11.7%) |
| Mar 2013 | - | $15.19 M(-7.7%) |
| Dec 2012 | $16.46 M(+68.8%) | $16.46 M(-5.3%) |
| Sept 2012 | - | $17.37 M(-14.7%) |
| June 2012 | - | $20.37 M(-2.7%) |
| Mar 2012 | - | $20.92 M(+114.6%) |
| Dec 2011 | $9.75 M(+1936.5%) | $9.75 M(+4491.9%) |
| Sept 2011 | - | $212.30 K(-56.9%) |
| June 2011 | - | $492.50 K(-16.7%) |
| Mar 2011 | - | $591.30 K(+23.5%) |
| Dec 2010 | $478.70 K | $478.70 K(-55.5%) |
| Sept 2010 | - | $1.08 M(-31.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2010 | - | $1.57 M(-22.1%) |
| Mar 2010 | - | $2.02 M(>+9900.0%) |
| Dec 2009 | $18.00 K(-83.0%) | $18.00 K(-88.3%) |
| Sept 2009 | - | $153.60 K(-47.9%) |
| June 2009 | - | $294.60 K(+27.8%) |
| Mar 2009 | - | $230.50 K(+117.5%) |
| Dec 2008 | $106.00 K(-83.7%) | $106.00 K(+196.9%) |
| Sept 2008 | - | $35.70 K(-93.8%) |
| June 2008 | - | $576.40 K(-49.1%) |
| Mar 2008 | - | $1.13 M(+74.4%) |
| Dec 2007 | $649.70 K(-78.6%) | $649.70 K(-68.0%) |
| Sept 2007 | - | $2.03 M(-57.6%) |
| June 2007 | - | $4.79 M(-44.9%) |
| Mar 2007 | - | $8.69 M(+186.9%) |
| Dec 2006 | $3.03 M(-69.2%) | $3.03 M(-22.6%) |
| Sept 2006 | - | $3.91 M(-35.3%) |
| June 2006 | - | $6.05 M(-29.1%) |
| Mar 2006 | - | $8.53 M(-13.2%) |
| Dec 2005 | $9.83 M(+984.9%) | $9.83 M(-17.2%) |
| Sept 2005 | - | $11.87 M(+1233.7%) |
| June 2005 | - | $889.90 K(+63.3%) |
| Mar 2005 | - | $545.00 K(-39.8%) |
| Dec 2004 | $905.70 K(-87.8%) | $905.70 K(-87.8%) |
| Sept 2004 | - | $7.41 M(-16.4%) |
| June 2004 | - | $8.87 M(-7.1%) |
| Mar 2004 | - | $9.54 M(+28.7%) |
| Dec 2003 | $7.41 M(+330.8%) | $7.41 M(+7161.3%) |
| Sept 2003 | - | $102.10 K(-78.6%) |
| June 2003 | - | $477.90 K(-58.3%) |
| Mar 2003 | - | $1.15 M(-33.4%) |
| Dec 2002 | $1.72 M(+8.1%) | $1.72 M(+358.0%) |
| Sept 2002 | - | $375.80 K(-15.6%) |
| June 2002 | - | $445.40 K(-52.3%) |
| Mar 2002 | - | $933.20 K(-41.4%) |
| Dec 2001 | $1.59 M(-40.2%) | $1.59 M(+261.3%) |
| Sept 2001 | - | $440.60 K(-57.2%) |
| June 2001 | - | $1.03 M(-60.1%) |
| Mar 2001 | - | $2.58 M(-3.1%) |
| Dec 2000 | $2.66 M(-23.9%) | $2.66 M(+56.7%) |
| Sept 2000 | - | $1.70 M(+5.9%) |
| June 2000 | - | $1.61 M(-48.4%) |
| Mar 2000 | - | $3.11 M(-11.0%) |
| Dec 1999 | $3.50 M(-39.7%) | $3.50 M(-5.4%) |
| Sept 1999 | - | $3.70 M(-9.8%) |
| June 1999 | - | $4.10 M(-18.0%) |
| Mar 1999 | - | $5.00 M(-13.8%) |
| Dec 1998 | $5.80 M(-31.8%) | $5.80 M(-17.1%) |
| Sept 1998 | - | $7.00 M(-15.7%) |
| June 1998 | - | $8.30 M(+18.6%) |
| Mar 1998 | - | $7.00 M(-17.6%) |
| Dec 1997 | $8.50 M(+269.6%) | $8.50 M(-14.1%) |
| Sept 1997 | - | $9.90 M(+330.4%) |
| June 1997 | - | $2.30 M(+64.3%) |
| Mar 1997 | - | $1.40 M(-39.1%) |
| Dec 1996 | $2.30 M | $2.30 M(-28.1%) |
| Sept 1996 | - | $3.20 M(+14.3%) |
| June 1996 | - | $2.80 M |
FAQ
- What is TG Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for TG Therapeutics?
- What is TG Therapeutics annual cash & cash equivalents year-on-year change?
- What is TG Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for TG Therapeutics?
- What is TG Therapeutics quarterly cash and cash equivalents year-on-year change?
What is TG Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of TGTX is $92.93 M
What is the all time high annual cash & cash equivalents for TG Therapeutics?
TG Therapeutics all-time high annual cash & cash equivalents is $553.44 M
What is TG Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, TGTX annual cash & cash equivalents has changed by -$9.37 M (-9.16%)
What is TG Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TGTX is $195.82 M
What is the all time high quarterly cash and cash equivalents for TG Therapeutics?
TG Therapeutics all-time high quarterly cash and cash equivalents is $553.44 M
What is TG Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, TGTX quarterly cash and cash equivalents has changed by +$44.92 M (+29.77%)